These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 15682251)

  • 21. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Generics: authorization to market and quality guarantees].
    De Muylder JA
    Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do international model drug control laws provide for drug availability?
    University of Wisconsin Pain & Policy Studies Group
    J Pain Palliat Care Pharmacother; 2009; 23(2):145-52. PubMed ID: 19492215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioequivalence and interchangeability of narrow therapeutic range drugs. Canadian Society for Pharmaceutical Sciences discussion.
    Palylyk-Colwell E; Jamali F; Dryden W; Friesen E; Koven S; Mohamed I; Osmond B; Alessi-Severini S; Sheldon L; Sheldon R; Tam Y; Tsuyuki R; Zhanel G
    J Pharm Pharm Sci; 1998; 1(1):2-7. PubMed ID: 10942966
    [No Abstract]   [Full Text] [Related]  

  • 26. Harmonization of regulatory approaches for evaluating therapeutic equivalence and interchangeability of multisource drug products: workshop summary report.
    Chen ML; Shah VP; Crommelin DJ; Shargel L; Bashaw D; Bhatti M; Blume H; Dressman J; Ducharme M; Fackler P; Hyslop T; Lutter L; Morais J; Ormsby E; Thomas S; Tsang YC; Velagapudi R; Yu LX
    Eur J Pharm Sci; 2011 Nov; 44(4):506-13. PubMed ID: 21946259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Generic drugs in developing countries].
    Trouiller P
    Sante; 1996; 6(1):21-6. PubMed ID: 8612010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Bioequivalence studies of pharmaceutical preparations].
    Vetchý D; Frýbortová K; Rabisková M; Danecková H
    Cas Lek Cesk; 2007; 146(5):431-3. PubMed ID: 17554963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 30. A Survey on One Health Approach in Colombia and Some Latin American Countries: From a Fragmented Health Organization to an Integrated Health Response to Global Challenges.
    Cediel Becerra NM; Olaya Medellin AM; Tomassone L; Chiesa F; De Meneghi D
    Front Public Health; 2021; 9():649240. PubMed ID: 34760857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Generic drugs, alternatives, substitutes, interchanges].
    Kolár J; Chalabala M
    Ceska Slov Farm; 1999 Mar; 48(2):59-64. PubMed ID: 10376417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceuticals issue brief: generic and therapeutic substitution: year end report--2004.
    Health Policy Tracking Service staff
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-14. PubMed ID: 15724310
    [No Abstract]   [Full Text] [Related]  

  • 33. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 34. Renal health models in Latin America: development of national programs of renal health.
    Depine S; Calderón RB
    Ren Fail; 2006; 28(8):649-64. PubMed ID: 17162423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of pharmaceutical data exclusivity laws in Latin America: is access to affordable medicine threatened?
    Cartagena RG; Attaran A
    Health Law J; 2009; 17():269-96. PubMed ID: 20608321
    [No Abstract]   [Full Text] [Related]  

  • 36. International prices and availability of pharmaceuticals in 2005.
    Danzon PM; Furukawa MF
    Health Aff (Millwood); 2008; 27(1):221-33. PubMed ID: 18180499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Politics and Policies of Regulating Generics in Latin America: A Survey of Seventeen States.
    Sweet CM
    J Health Polit Policy Law; 2017 Jun; 42(3):485-512. PubMed ID: 28213391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Judicialization of access to medicines in four Latin American countries: a comparative qualitative analysis.
    Vargas-Pelaez CM; Rover MRM; Soares L; Blatt CR; Mantel-Teeuwisse AK; Rossi FA; Restrepo LG; Latorre MC; López JJ; Bürgin MT; Silva C; Leite SN; Farias MR
    Int J Equity Health; 2019 Jun; 18(1):68. PubMed ID: 31154999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EMEA tackles "generic" biologic drug issues.
    Rice M
    J Natl Cancer Inst; 2006 Apr; 98(7):435-6. PubMed ID: 16595776
    [No Abstract]   [Full Text] [Related]  

  • 40. CFTR gene analysis in Latin American CF patients: heterogeneous origin and distribution of mutations across the continent.
    Pérez MM; Luna MC; Pivetta OH; Keyeux G
    J Cyst Fibros; 2007 May; 6(3):194-208. PubMed ID: 16963320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.